1-5 of 5
midostaurin
Close
Sort by
Journal Articles

Clonal evolution and heterogeneity in advanced systemic mastocytosis revealed by single-cell DNA sequencing

Ken-Hong Lim, Jo-Ning Wu, To-Yu Huang, Jie-Yang Jhuang, Yu-Cheng Chang, Huan-Chau Lin, Yi-Hao Chiang, Ying-Wen Su, Caleb Gon-Shen Chen, Yi-Fang Chang, Johnson Lin
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1733–1736.
https://doi.org/10.1182/bloodadvances.2020003980
Published: 2021
Includes: Supplemental data
Journal Articles

Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL

Clinical Trials & Observations
Ina-Katrin Siekmann, Kevin Dierck, Sebastian Prall, Marianne Klokow, Julia Strauss, Sophia Buhs, Antonina Wrzeszcz, Michael Bockmayr, Florian Beck, Magdalena Trochimiuk, Kristina Gottschling, Victoria Martens, Melissa Khosh-Naucke, Helwe Gerull, Jürgen Müller, Lena Behrmann, Martin Blohm, René P. Zahedi, Irmela Jeremias, Albert Sickmann, Peter Nollau, Martin A. Horstmann
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2554–2567.
https://doi.org/10.1182/bloodadvances.2018020693
Published: 2018
Includes: Supplemental data
Journal Articles

Stone RM, Manley PW, Larson RA, Capdeville R. Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood Adv . 2018;2(4):444-453.

Journal: Blood Advances
Blood Adv (2018) 2 (7): 787.
https://doi.org/10.1182/bloodadvances.2018018481
Published: 2018
Journal Articles

Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis

Clinical Trials & Observations
Richard M. Stone, Paul W. Manley, Richard A. Larson, Renaud Capdeville
Journal: Blood Advances
Blood Adv (2018) 2 (4): 444–453.
https://doi.org/10.1182/bloodadvances.2017011080
Published: 2018
Journal Articles

The role of targeted therapy in the management of patients with AML

Clinical Trials & Observations
Alexander E. Perl
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2281–2294.
https://doi.org/10.1182/bloodadvances.2017009829
Published: 2017